ASTRAZENECA PLC - Significant Ownership

Signature - Title
AstraZeneca PLC - Adrian Kemp, Company Secretary
Location
Cambridge, United Kingdom
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by ASTRAZENECA PLC.

Significant Ownership of ASTRAZENECA PLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CLLS Cellectis S.A. Ordinary shares, nominal value of EUR0.05 per ordinary share 44% $55.4M 44M AstraZeneca PLC Jan 23, 2025
CDT Conduit Pharmaceuticals Inc. Common Stock, par value $0.0001 per share 1.1% $3.69K 73.9K AstraZeneca PLC Mar 31, 2025

Schedules 13D/G Reported by ASTRAZENECA PLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.